Steven R. King

CIK: 0001622052

Transaction Breakdown

Open Market Buys (P)2 (25.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (12.5%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (12.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

JAGX

Jaguar Health, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

JAGX
Jaguar Health, Inc.
Dec 11, 2025
Award(A)
Direct
11.7K shares-
JAGX
Jaguar Health, Inc.
Jun 24, 2025
Award(A)
Convertible Promissory Note
Direct
3.8K shares at avg. $20.00-
JAGX
Jaguar Health, Inc.
Jun 24, 2025
Award(A)
Warrant to Purchase Common Stock
Direct
7.3K shares-
JAGX
Jaguar Health, Inc.
Jun 24, 2025
Disposition(D)
Convertible Promissory Note
Direct
3.6K shares at avg. $20000.00-
JAGX
Jaguar Health, Inc.
May 17, 2025
Exercise(M)
Direct
1 shares-
JAGX
Jaguar Health, Inc.
Mar 31, 2025
Purchase(P)
Convertible Promissory Note
Direct
3.6K shares at avg. $20000.00-
JAGX
Jaguar Health, Inc.
Mar 31, 2025
Purchase(P)
Warrant to Purchase Common Stock
Direct
3.6K shares-
JAGX
Jaguar Health, Inc.
Oct 8, 2024
Award(A)
Direct
4.9K shares-

		Type	Shares	Price		Ownership
Dec 11, 2025	JAGX Jaguar Health, Inc.	Award(A)	11,740	-	$0	Direct
Jun 24, 2025	JAGX Jaguar Health, Inc.	Award(A) Convertible Promissory Note	3,785	$20.00	-	Direct
Jun 24, 2025	JAGX Jaguar Health, Inc.	Award(A) Warrant to Purchase Common Stock	7,304	-	-	Direct
Jun 24, 2025	JAGX Jaguar Health, Inc.	Disposition(D) Convertible Promissory Note	3,600	$20000.00	-	Direct
May 17, 2025	JAGX Jaguar Health, Inc.	Exercise(M)	1	-	-	Direct
Mar 31, 2025	JAGX Jaguar Health, Inc.	Purchase(P) Convertible Promissory Note	3,600	$20000.00	-	Direct
Mar 31, 2025	JAGX Jaguar Health, Inc.	Purchase(P) Warrant to Purchase Common Stock	3,600	-	-	Direct
Oct 8, 2024	JAGX Jaguar Health, Inc.	Award(A)	4,922	-	$0	Direct

1-8 of 8 transactions

About King Steven R.

King Steven R. (SEC CIK 0001622052) files insider reports with the SEC as Officer of Jaguar Health, Inc. (JAGX).

Signal8 holds 5 ownership filings by King Steven R., all Form 4s, filed between Oct 10, 2024 and Jan 21, 2026. Those filings report 8 transactions, from Oct 8, 2024 to Dec 11, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on King Steven R.'s filings is in SAN FRANCISCO, CA.

Recent filings by King Steven R.

Dec 11, 2025: Grant or award of JAGX shares (Form 4, code A).
Jun 24, 2025: Grants or awards of JAGX derivative securities (2 lines, Form 4, code A).
Jun 24, 2025: Disposition to issuer transaction of JAGX derivative securities (Form 4, code D).
May 17, 2025: Option exercise of JAGX shares (Form 4, code M).
Mar 31, 2025: Open-market purchases of JAGX derivative securities (2 lines, Form 4, code P).

Other insiders filing for Jaguar Health, Inc. (JAGX)

MICEK JOHN, Director
CONTE LISA A
Wolin Jonathan S.
Chaturvedi Pravin R, Chief Scientific Officer
BOCHNOWSKI JAMES J, Director
Siegel Jonathan B., Director

How to read Form 4 transaction codes